Cargando…
Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis
BACKGROUND: Mycobacterium tuberculosis remains a global health problem and clinical management is complicated by difficulty in discriminating between latent infection and active disease. While M. tuberculosis-reactive antibody levels are heterogeneous, studies suggest that levels of IgG glycosylatio...
Autores principales: | Lu, Lenette L, Das, Jishnu, Grace, Patricia S, Fortune, Sarah M, Restrepo, Blanca I, Alter, Galit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661770/ https://www.ncbi.nlm.nih.gov/pubmed/32060529 http://dx.doi.org/10.1093/infdis/jiz643 |
Ejemplares similares
-
Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
por: Grace, Patricia S., et al.
Publicado: (2021) -
Leveraging Antibody, B Cell and Fc Receptor Interactions to Understand Heterogeneous Immune Responses in Tuberculosis
por: Carpenter, Stephen M., et al.
Publicado: (2022) -
Antibody glycosylation in inflammation, disease and vaccination
por: Alter, Galit, et al.
Publicado: (2018) -
T-Cell Immunophenotyping Distinguishes Active From Latent Tuberculosis
por: Pollock, Katrina M., et al.
Publicado: (2013) -
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
por: Lofano, Giuseppe, et al.
Publicado: (2018)